STOCK TITAN

Cellebrite (CLBT) Rule 144 Notice — 25,810 Shares via Morgan Stanley

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for proposed sale of securities by an insider or affiliate. The filing reports an intended sale of 25,810 shares of Common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $454,514.10. The shares are listed on NASDAQ and the approximate sale date provided is 09/22/2025. The shares were acquired as restricted stock units from the issuer on 02/15/2023, and no related securities sales were reported in the prior three months. Several filer and issuer identification fields are left blank in the supplied content.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine Rule 144 sale notice showing an insider sale of $454k worth of shares; appears procedural and non-material to company capitalization.

The filing documents a proposed sale under Rule 144 of 25,810 common shares via Morgan Stanley, valued at $454,514.10, with an approximate sale date of 09/22/2025. The shares were originally granted as restricted stock units on 02/15/2023. The notice indicates no sales in the prior three months. Based solely on the information provided, the transaction is a standard disclosure required for restricted or control securities being resold into the market and does not, by itself, indicate change in company operations or financial condition.

TL;DR: Disclosure follows compliance requirements; absence of filer identity limits assessment of insider role or governance implications.

The form includes the required representation regarding absence of undisclosed material information and notes the shares were acquired from the issuer as RSUs on 02/15/2023. The broker and transaction details are provided, but key identifying fields for the filer and issuer are blank in the content provided. Without the filer’s identity or relationship to the issuer, it is impossible to assess whether this sale reflects routine vesting, planned diversification, or any governance signal. The filing meets Rule 144 notification format but lacks contextual identifiers in the supplied extract.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the Form 144 filed for CLBT report?

The notice reports a proposed sale of 25,810 common shares valued at $454,514.10 to be sold on or about 09/22/2025 via Morgan Stanley Smith Barney LLC on NASDAQ.

How were the shares being sold acquired?

The shares were acquired as Restricted Stock Units from the issuer on 02/15/2023.

Does the filing show any sales in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Is the filer or issuer identity provided in the document extract?

No. Key fields such as the filer CIK/name and the issuer name/address are blank in the supplied content.

What representation does the signer make on this Form 144?

The person for whose account the securities will be sold represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Cellebrite Di Ltd

NASDAQ:CLBT

CLBT Rankings

CLBT Latest News

CLBT Latest SEC Filings

CLBT Stock Data

4.58B
126.44M
44.61%
49.91%
2.36%
Software - Infrastructure
Technology
Link
Israel
Petah Tikva